Priority 17 from the Autosomal Dominant Polycystic Kidney Disease Project

UNCERTAINTY: Why do the symptoms and severity of polycystic liver disease (PLD) vary between people? (Priority 17)
Overall ranking 17
JLA question ID 0103/17
Explanatory note Not available for this PSP

No evidence identified  

Health Research Classification System category Renal and urogenital 
Extra information provided by this project
Original uncertainty examples How does liver size, in people with ADPKD, correlate with the symptoms of Polycystic liver disease and quality of life? ~ What are the effects of hormonal therapies including low-dose oral contraceptives, topical estrogens and hormonal replacement therapy on liver cyst growth in people with ADPKD? 
Submitted by Autosomal Dominant Polycystic Kidney Disease (ADPKD): Report from a Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference
Project information
Project unique ID 0103
Project name Autosomal Dominant Polycystic Kidney Disease
Total number of uncertainties identified by this project.

35 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)

Date of priority setting workshop 15 December 2020